AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Intel CEO Lip-Bu Tan: "We will remain focused" on cutting costs and complexity
2
a16z’s David Haber: “AI is making markets that weren’t attractive to software companies suddenly very compelling”
3
OpenAI raising $40 billion at a $300 billion valuation in record funding round
4
"We saved $350 million last year using AI agents"
5
Deel and Rippling corporate espionage case takes a turn as accused ‘spy’ agrees to cooperate
More news

aMoon

12 stories about aMoon
ד"ר דורון בהר igentify

Marius Nacht, OurCrowd Back Igentify in $10.5 Million Round

16.09.19|Meir Orbach
Igentify develops a digital genetic testing analyzer for various genotyping technologies like microarray and next-generation sequencing (NGS), and offers machine-generated personalized genetic counseling
ליהיא סגל DayTwo

Israeli Gut Microbiome Analysis Startup DayTwo Raises $31 Million

26.06.19|Hagar Ravet
DayTwo offers personalized nutrition optimization suggestions based on feces analysis, designed to reduce risk of diabetes and other metabolic diseases
קרן אמון מימין ד"ר תומר ברקוביץ ד"ר יאיר שינדל טוד סון איציק דבש

Life Sciences Venture Fund aMoon Appoints Fourth Partner

02.05.19|Hagar Ravet
Tomer Berkovitz, who served as aMoon’s managing director and CFO, was appointed partner
איבקס ibex

Dell Backs Cancer Diagnosis Startup Ibex

19.03.19|Hagar Ravet
Ibex develops an AI-driven diagnostic system using data from digitized glass slides and electronic medical records to reveal cancer diagnoses for tissue biopsies
מוסף כאב ראש מיגרנה

Migraine Treatment Startup Theranica Raises $35 Million

18.03.19|Adi Pick
Theranica develops electrical nerve stimulation (ENS) technology for controlling migraines
בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million

06.03.19|Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
מריוס נכט 1

Life Sciences Venture Fund aMoon Raises $600 Million for Second Fund, Report Says

09.01.19|Hagar Ravet
The Israel-based firm first announced in April it was raising a second fund with a hard cap of $750 million
בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Life Sciences Venture Fund aMoon Nearing Cap of Second Fund, Says Co-Founder

08.11.18|Lilach Baumer
The Israel-based firm announced in April it is raising a second, $500 million fund with a hard cap of $750 million. Credit Suisse is a major investor
מריוס נכט 1

Credit Suisse to Invest $250 Million in Israel-based Life Sciences Venture Fund aMoon

16.05.18|Lilach Baumer
Credit Suisse and aMoon announced a strategic partnership Wednesday. The latter was founded by one of the co-founders of Firewall pioneer Check Point
מריוס נכט 1

Marius Nacht Invests in Swiss Mobile Banking Startup Numbrs

01.05.18|CTech
Numbrs has developed a mobile banking app that aggregates bank accounts and credit card data into a personalized financial service
מריוס נכט 2

Venture Capital Firm aMoon Aims to Raise $500 Million or More For a Second Fund

17.04.18|Lilach Baumer
Established in 2016, aMoon invests in life sciences and healthcare companies, with a focus on Israeli tech
רופא רפואה טכנולוגיה ממוחשבת

Predictive Patient Care Startup Medial EarlySign Raises $30 Million

07.03.18|Lilach Baumer
The round was led by life science fund aMoon Partners, with participation by Li Ka-Shing's Horizon Ventures
Previous Articles